Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Tezepelumab-ekko 210 Mg / 1.91 Ml Subq (CDM 4070236) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 12, 2026 , from http://ppman.hank.ai/transparency/procedure/4070236/by-state?code_type=CDM
“Tezepelumab-ekko 210 Mg / 1.91 Ml Subq (CDM 4070236) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/4070236/by-state?code_type=CDM. Accessed
October 12, 2026 .
“Tezepelumab-ekko 210 Mg / 1.91 Ml Subq (CDM 4070236) by State,” HANK Price Transparency ,
accessed October 12, 2026 ,
http://ppman.hank.ai/transparency/procedure/4070236/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
4070236 — Tezepelumab-ekko 210 Mg / 1.91 Ml Subq
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$10,000
National median
$4,639 – $12,086
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 4070236 (CDM), with interquartile range
State Median p25 p75
VT $10,000 $4,639 $12,086